A federal judge in Wisconsin has denied GlaxoSmithKline’s claim that an FDA-approved label shields it from liability for personal injury claims involving the anti-anxiety drug Paxil. The plaintiffs’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results